Dalfampridine

Dalfampridine (4-aminopyridine) is a broad-spectrum voltage-gated potassium channel blocker used to improve walking ability in patients with multiple sclerosis (MS). It enhances nerve conduction in demyelinated axons. Mediocon Inc supplies pharmaceutical-grade Dalfampridine meeting USP, BP, EP, and IP standards.

Key Features

• Analgesic, antipyretic & anti-inflammatory
• USP/BP/IP compliant quality
• Widely used in cardiovascular therapy
• Suitable for tablet and effervescent formulations

Applications

• Multiple sclerosis (MS) walking improvement
• Extended-release tablet formulations
• Neurological disorder therapy
• Clinical research MS applications

Why Choose Mediocon

• ISO 9001:2015 & GMP certified manufacturing
• Consistent batch-to-batch quality with full CoA
• Export-ready documentation: COO, MSDS, DMF
• Flexible MOQ for both R&D and commercial scale
• Dedicated QA support for regulatory filings